Biblio

Export 2 results:
Author Title Type [ Year(Asc)]
Filters: Author is Franzini, Anca  [Clear All Filters]
2015
[Anonymous] (2015).  Gene expression signatures predictive of bevacizumab/erlotinib therapeutic benefit in advanced non-squamous non-small cell lung cancer patients (SAKK 19/05 trial). Clinical Cancer Research. clincanres––3135.
2014
[Anonymous] (2014).  Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC). European Respiratory Journal. 44, P821.